IRadimed Corporation
IRMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $21,202 | $20,409 | $19,511 | $19,389 |
| % Growth | 3.9% | 4.6% | 0.6% | – |
| Cost of Goods Sold | $4,708 | $4,454 | $4,668 | $4,628 |
| Gross Profit | $16,494 | $15,955 | $14,843 | $14,761 |
| % Margin | 77.8% | 78.2% | 76.1% | 76.1% |
| R&D Expenses | $674 | $877 | $624 | $570 |
| G&A Expenses | $0 | $4,280 | $4,611 | $3,873 |
| SG&A Expenses | $8,986 | $8,290 | $8,787 | $8,391 |
| Sales & Mktg Exp. | $0 | $4,010 | $4,176 | $4,517 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9,661 | $9,167 | $9,411 | $8,961 |
| Operating Income | $6,834 | $6,788 | $5,431 | $5,800 |
| % Margin | 32.2% | 33.3% | 27.8% | 29.9% |
| Other Income/Exp. Net | $464 | $539 | $514 | $544 |
| Pre-Tax Income | $7,298 | $7,327 | $5,945 | $6,344 |
| Tax Expense | $1,721 | $1,553 | $1,258 | $1,198 |
| Net Income | $5,577 | $5,774 | $4,687 | $5,147 |
| % Margin | 26.3% | 28.3% | 24% | 26.5% |
| EPS | 0.438 | 0.45 | 0.37 | 0.41 |
| % Growth | -2.6% | 21.6% | -9.8% | – |
| EPS Diluted | 0.434 | 0.45 | 0.37 | 0.4 |
| Weighted Avg Shares Out | 12,721 | 12,715 | 12,714 | 12,684 |
| Weighted Avg Shares Out Dil | 12,860 | 12,830 | 12,826 | 12,784 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $384 | $592 | $194 | $195 |
| EBITDA | $7,681 | $7,920 | $5,626 | $6,539 |
| % Margin | 36.2% | 38.8% | 28.8% | 33.7% |